New pill tested to boost Insulin's power in diabetes
NCT ID NCT02220920
Summary
This study tested whether adding a pill called canagliflozin to insulin therapy helps people with type 2 diabetes manage their blood sugar better. It involved 146 Japanese adults whose blood sugar was still too high despite using insulin, diet, and exercise. Participants took either the real pill or a placebo (sugar pill) for 16 weeks to compare effects on blood sugar levels, weight, and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Reserch site
Chugoku, Japan
-
Reserch site
Chūbu, Japan
-
Reserch site
Hokkaido, Japan
-
Reserch site
Kanto, Japan
-
Reserch site
Kinki, Japan
-
Reserch site
Kyushu, Japan
-
Reserch site
Tōhoku, Japan
Conditions
Explore the condition pages connected to this study.